Clinical Guide
Smart532
™
A-6 UM-1151440EN, Rev. C, May 2016
Hemostasis of graft site
● Vestibuloplasty
● Soften Gutta Percha
● Treatment of canker sores, herpetic lesions, and aphthous ulcers
● Laser-assisted bleaching/whitening
A.2.5 Device energy delivery options
Diabetic Retinopathy including Macular
Edema or Proliferative Retinopathy,
Proliferative Diabetic Retinopathy (PDR),
Central Serous Chorioretinopathy (CSCR),
Macular Edema or Proliferative Retinopathy
associated with Branch Retinal Vein
The Smart532 system emits a laser beam with a wavelength of 532 nm
(green). This type of energy can be used to treat several ocular conditions
in both the anterior and posterior segments of the eye. It is particularly
well suited for treating the eye because it is not absorbed in aqueous media
and has minimal effect on transparent tissues and materials. Hence the
laser energy can efficiently penetrate the cornea, aqueous humor, lens, and
vitreous humor to target tissues of interest such as the retina in the
posterior segment and the trabecular meshwork in the anterior segment.
Laser energy can be delivered by means of a slit lamp, a laser indirect
ophthalmoscope or an endoprobe.
See Section A.2.1.
Diabetic Retinopathy including Macular Edema
or Proliferative Retinopathy
Proliferative Diabetic Retinopathy (PDR)
Pan-retinal
photocoagulation
Macular Edema or Proliferative Retinopathy
associated with Central Retinal Vein Occlusion
(CRVO) or Branch Retinal Vein Occlusion
retinal
photocoagulation
Central Serous ChorioRetinopathy (CSCR)
Choroidal Neovascularization (CNV) secondary
Photocoagulation
Indications for
Use
A.3.1.1. Clinical conditions
and associated
treatment
To Next Page
Loading...
